| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 514526000 | Acyclic | 20 |
| 20080319063 | CURING ACCELERATOR AND METHOD OF MAKING - A sterilized cyanoacrylate adhesive composition including a cyanoacrylate composition and a cure speed enhancer, wherein the sterilized cyanoacrylate adhesive composition does not cure upon sterilization. A kit for applying the sterilized cyanoacrylate adhesive composition, including the cyanoacrylate adhesive composition and an applicator. A method of making the sterilized cyanoacrylate adhesive composition, by adding a cure speed enhancer to a cyanoacrylate adhesive composition and sterilizing the composition. A method of applying the sterilized cyanoacrylate adhesive composition to tissue by applying the sterilized cyanoacrylate adhesive composition as a liquid, and quickly curing the sterilized cyanoacrylate adhesive composition. A method of sealing tissue by applying the sterilized cyanoacrylate adhesive composition as a liquid to tissue to be sealed, quickly curing the sterilized cyanoacrylate adhesive composition, and sealing the tissue. | 12-25-2008 |
| 20100056626 | COSMETIC PRODUCT FOR THE TREATMENT OF CICATRICIAL TISSUES - A method for cosmetic treatment of cicatricial tissues comprising the step of applying to the cicatricial tissue a cosmetic product which contains one or more cyanoacrylates. | 03-04-2010 |
| 20100160430 | ORGANIC SULFUR COMPOUND AND ITS USE FOR CONTROLLING HARMFUL ARTHROPOD - There is provided an organic sulfur compound having an excellent controlling effect on harmful arthropods represented by the formula (I): wherein, R | 06-24-2010 |
| 20120157524 | 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN - The present invention relates to purified 3-methanesulfonylpropionitrile or a pharmaceutically acceptable salt thereof, and a method for preparing such compound. The compound has at least 90% (w/w) purity. The present invention is also directed to a pharmaceutical composition comprises the purified compound and a pharmaceutically acceptable carrier. The present invention is further directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering 3-methanesulfonylpropionitrile or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. | 06-21-2012 |
| 20120184613 | SULFUR-CONTAINING COMPOUND AND USE THEREOF - There is provided a sulfur-containing compound having a controlling effect on arthropod pests represented by the formula (I): | 07-19-2012 |
| 20130053439 | DISINFECTANT COMPOSITION - The invention relates to a disinfectant composition (i) comprising a combination of citric acid or a physiologically acceptable salt thereof as component (A), and poly(hexamethylene-biguanide) (PHMB) or a physiologically acceptable salt thereof as component (B) and/or (ii) exhibiting a log reduction of | 02-28-2013 |
| 20130172410 | 3-METHANESULFONYLPROPIONITRILE FOR TREATING INFLAMMATION AND PAIN - The present invention relates to purified 3-methanesulfonylpropionitrile or a pharmaceutically acceptable salt thereof, and a method for preparing such compound. The compound has at least 90% (w/w) purity. The present invention is also directed to a pharmaceutical composition comprises the purified compound and a pharmaceutically acceptable carrier. The present invention is further directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering 3-methanesulfonylpropionitrile or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. | 07-04-2013 |
| 20130324603 | PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION AND PAIN - The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and a methanesulfonylalkylnitrile compound, or a pharmaceutically acceptable salt or solvate thereof. The present invention is also directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering a methanesulfonylalkylnitrile compound or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. | 12-05-2013 |
| 20140235712 | CONFORMABLE COATING AND COMPOSITION - The disclosed conformable coating provides a highly durable and resilient film useful for protecting and repairing surfaces such as skin and mucous membranes. A conformable coating composition comprises an elastomer, a volatile liquid, wherein the volatile liquid is at least 40% wt. of the total composition and the composition has a viscosity less than 1,000 cps. Disclosed is a conformable film that comprises an elastomer on a substrate, wherein the coating weight is from 1 to 30 mg/in | 08-21-2014 |
| 20150087702 | METHODS AND COMPOSITIONS FOR REDUCING ALCOHOL TOXICITY - The present invention comprises methods and compositions for reducing ethanol toxicity due to accumulation of acetaldehyde in a cell. A method comprises administering to a cell a composition comprising a compound that increases the expression, the amount of, and/or the activity of at least one member of the aldehyde dehydrogenase superfamily. | 03-26-2015 |
| 20150094366 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN - The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 3-(methylthio)propionitrile, or a pharmaceutically acceptable salt thereof. The present invention is directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering ω-(methylthio)alkylnitriles such as 3-(methylthio)propionitrile, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. | 04-02-2015 |
| 20160150780 | COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES | 06-02-2016 |
| 20160184255 | COMPOUNDS FOR TREATING INFLAMMATION AND PAIN - The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 3-(methylthio)propionitrile, or a pharmaceutically acceptable salt thereof. The present invention is directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering ω-(methylthio)alkylnitriles such as 3-(methylthio)propionitrile, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. | 06-30-2016 |
| 20170231944 | 4-METHYLSULFONYL-2-BUTENENITRILE AND ITS PHARMACEUTICAL USE | 08-17-2017 |
| 514527000 | C=O other than as ketone or aldehyde | 6 |
| 20120029071 | COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING RADIATION INJURY - The invention provides compositions and methods featuring Nrf2 activators for treating or preventing radiation-associated tissue damage. | 02-02-2012 |
| 514528000 | C(=O)N containing | 5 |
| 20110152365 | DISINFECTANT FORMULATIONS THAT REMAIN LIQUID AT LOW TEMPERATURE - In the present invention, there is provided a disinfectant composition comprising
| 06-23-2011 |
| 20120172430 | COMPOSITIONS OF DIBROMOMALONAMIDE AND THEIR USE AS BIOCIDES - A biocidal composition comprising 2,2-dibromomalonamide and 2,2-dibromo-3-nitrilopropionamide, and its use for the control of microorganisms in aqueous and water-containing systems. | 07-05-2012 |
| 20130046013 | SALICYLATE FATTY ACID DERIVATIVES - Fatty acid conjugates of salicylate derivatives and compositions thereof are disclosed. Further disclosed are methods for treating various diseases comprising the administration of an effective amount of at least one compound according to the present disclosure. | 02-21-2013 |
| 20130303608 | STABLE AQUEOUS SUSPENSIONS OF DBNPA, THEIR PREPARATION AND USES THEREOF AS BIOCIDES - The present invention discloses novel biocide composition comprising 2,2-dibromo-3-nitrilopropionamide (DBNPA) being in the form of a stable aqueous suspension. Further are disclosed the preparation of these compositions and their biocidal uses. | 11-14-2013 |
| 20150351383 | Biocide composition and method for treating water - The present invention provides a biocide composition comprising a biocide and a carrier, wherein the biocide is soluble in the carrier. The carrier may comprise polyethylene glycol ester. The present invention also provides a method for controlling biofilms by eliminating and/or preventing microorganisms in an aqueous environment. | 12-10-2015 |
